{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:30:43Z","timestamp":1758709843910},"reference-count":20,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.3892\/mco.2017.1225","type":"journal-article","created":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T11:44:48Z","timestamp":1492775088000},"page":"876-880","source":"Crossref","is-referenced-by-count":6,"title":["p53 protein expression in patients with myelodysplasia treated with allogeneic bone marrow transplantation"],"prefix":"10.3892","volume":"6","author":[{"given":"Achille","family":"Pich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Godio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Davico Bonino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,4,21]]},"reference":[{"key":"key20180107152426_b1-mco-0-0-1225","first-page":"88","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Brunning","year":"2008","edition":"4th"},{"key":"key20180107152426_b2-mco-0-0-1225","doi-asserted-by":"crossref","first-page":"678","DOI":"10.2174\/156652411797536732","article-title":"Cytogenetic and molecular abnormalities in myelodysplastic syndrome","volume":"11","author":"Nagoshi","year":"2011","journal-title":"Curr Mol Med"},{"key":"key20180107152426_b3-mco-0-0-1225","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1182\/blood.V85.8.2189.bloodjournal8582189","article-title":"TP53 mutations emerge at early phase of myelodysplastic syndrome and are associated with complex chromosomal abnormalities","volume":"85","author":"Kaneko","year":"1995","journal-title":"Blood"},{"key":"key20180107152426_b4-mco-0-0-1225","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1200\/JCO.2001.19.5.1405","article-title":"Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype and a poor prognosis","volume":"19","author":"Christiansen","year":"2001","journal-title":"J Clin Oncol"},{"key":"key20180107152426_b5-mco-0-0-1225","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1056\/NEJMoa1013343","article-title":"Clinical effect of point mutations in myelodysplastic syndromes","volume":"364","author":"Bejar","year":"2011","journal-title":"N Engl J Med"},{"key":"key20180107152426_b6-mco-0-0-1225","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1177\/40.7.1607637","article-title":"p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry","volume":"40","author":"Kerns","year":"1992","journal-title":"J Histochem Cytochem"},{"key":"key20180107152426_b7-mco-0-0-1225","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0140-6736(90)90801-B","article-title":"Increased expression of mutant forms of p53 oncogene in primary lung cancer","volume":"335","author":"Iggo","year":"1990","journal-title":"Lancet"},{"key":"key20180107152426_b8-mco-0-0-1225","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2141.2007.06649.x","article-title":"Aberrant nuclear p53 protein expression detected by immunohistochemistry is associated with hemizygous P53 deletion and poor survival for multiple myeloma","volume":"138","author":"Chang","year":"2007","journal-title":"Br J Haematol"},{"key":"key20180107152426_b9-mco-0-0-1225","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1309\/AJCPHC85DGAXZDBE","article-title":"p53 nuclear expression correlates with hemizygous TP53 deletion and predicts an adverse outcome for patients with relapsed\/refractory multiple myeloma treated with lenalidomide","volume":"137","author":"Chen","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"key20180107152426_b10-mco-0-0-1225","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1309\/AJCPEPX1C7HHFELK","article-title":"Aberrant nuclear p53 expression predicts hemizygous 17p (TP53) deletion in chronic lymphocytic leukemia","volume":"133","author":"Chang","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"key20180107152426_b11-mco-0-0-1225","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1200\/JCO.2010.31.8576","article-title":"TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression","volume":"29","author":"J\u00e4dersten","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20180107152426_b12-mco-0-0-1225","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/bjh.12203","article-title":"TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis","volume":"160","author":"Kulasekararaj","year":"2013","journal-title":"Br J Haematol"},{"key":"key20180107152426_b13-mco-0-0-1225","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.3324\/haematol.2014.104760","article-title":"Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia","volume":"99","author":"M\u00fcller-Thomas","year":"2014","journal-title":"Haematologica"},{"key":"key20180107152426_b14-mco-0-0-1225","first-page":"521","article-title":"Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: An immunohistochemical study of bone marrow biopsies","volume":"6","author":"Orazi","year":"1993","journal-title":"Mod Pathol"},{"key":"key20180107152426_b15-mco-0-0-1225","first-page":"338","article-title":"p53 expression in myeloid cells of myelodysplastic syndromes. Association with evolution of overt leukemia","volume":"145","author":"Kitagawa","year":"1994","journal-title":"Am J Pathol"},{"key":"key20180107152426_b16-mco-0-0-1225","first-page":"1120","article-title":"Expression of p53, MDM2, p21waf1, bcl-2, and retinoblastoma gene proteins in myelodysplastic syndrome after autologous bone marrow transplantation for lymphoma","volume":"10","author":"Brynes","year":"1997","journal-title":"Mod Pathol"},{"key":"key20180107152426_b17-mco-0-0-1225","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3324\/haematol.2013.098103","article-title":"p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)","volume":"99","author":"Saft","year":"2014","journal-title":"Haematologica"},{"key":"key20180107152426_b18-mco-0-0-1225","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1200\/JCO.2008.18.2246","article-title":"Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes","volume":"27","author":"Porta","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20180107152426_b19-mco-0-0-1225","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.hoc.2010.02.005","article-title":"Prognostic classification and risk assessment in myelodysplastic syndromes","volume":"24","author":"Cazzola","year":"2010","journal-title":"Hematol Oncol Clin North Am"},{"key":"key20180107152426_b20-mco-0-0-1225","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1182\/blood.V81.11.3022.3022","article-title":"Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia","volume":"81","author":"Sugimoto","year":"1993","journal-title":"Blood"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2017.1225\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T01:45:19Z","timestamp":1601948719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2017.1225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,21]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,4,21]]},"published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.3892\/mco.2017.1225"],"URL":"https:\/\/doi.org\/10.3892\/mco.2017.1225","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,21]]}}}